Results 261 to 270 of about 1,029,454 (311)

Worldwide trends in metabolic syndrome from 2000 to 2023: a systematic review and modelling analysis. [PDF]

Nat Commun
Noubiap JJ, Nansseu JR, Nyaga UF, Ndoadoumgue AL, Ngouo AT, Tounouga DN, Tianyi FL, Foka AJ, Lontchi-Yimagou E, Nkeck JR, Bigna JJ.   +10 more
europepmc   +1 more source

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

British Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić, Yusuf Ziya Sener, Marijana Vučković, Joseph Edgar Blais, Almir Fajkić, Emina Sher, Mislav Radić, Josipa Radić   +7 more
wiley   +1 more source

Global, regional, and national burden of chronic hepatitis B, 1990-2021, and projections to 2030: An urgent call for action to achieve hepatitis B elimination goals by 2030. [PDF]

Hum Vaccin Immunother
Shen F, Li B, Lv H, Li Z, Li D, Yang H, Cai W, Hu Y, Zhang Y, Zhao Y, Chen H, Liu Y, Deng Y.   +12 more
europepmc   +1 more source

Analysis of interstitial lung disease in pharmacovigilance databases: Coding challenges and interpretation biases—An update

British Journal of Clinical Pharmacology, EarlyView.
Aim Clinically, interstitial lung disease (ILD) is a heterogeneous group of respiratory disorders. Due to their low incidence, pharmacovigilance database analysis is useful to detect them. Precise diagnosis is challenging as well as coding in these databases. Query criteria are among the key elements for a good signal detection.
Romane Freppel, Adeline Benis, Philippe Bonniaud, Jean‐Luc Faillie, Aurélie Grandvuillemin   +4 more
wiley   +1 more source

Trends and burden of inflammatory bowel disease in children (aged 0-14 years) in Asia and Europe, 1990-2021: a global burden of disease 2021 analysis. [PDF]

Ann Med
Cao W, Han Y, Jin X, Yang M, Ye Q, Li Y, Wang Q, Mei Z, Zheng.   +8 more
europepmc   +1 more source

The burden of chronic kidney disease attributable to diet low in whole grains from 1990 to 2021: a global, regional and national analysis. [PDF]

Front Nutr
Zhao Z, Sun P, Xia Z, Zhang S, Xu M, Li J, Xu P.   +6 more
europepmc   +1 more source

Global trends, decomposition analysis, inequality assessment, and economic projections of tracheal, bronchus, and lung cancer. [PDF]

Front Public Health
Li W, Cong Y, Liu X, Lyu Z, Chen K.
europepmc   +1 more source

Estimates and projections of the global economic cost of breast cancers from 2021 to 2050. [PDF]

Front Endocrinol (Lausanne)
Mao Y, Chu X, Xie F, Fu L, Ding Z, Zhang W, Zhang Q, Tang C, Zhu S, Cao W, Hu B.   +10 more
europepmc   +1 more source

Global burden and cross-country inequalities of age-related eye diseases from 1990 to 2021: a comprehensive analysis of temporal trends and socioeconomic disparities. [PDF]

Eye Vis (Lond)
Li K, Tang J, Zhang Z, Li X, Zheng Y, Jiang D, Sun J.   +6 more
europepmc   +1 more source